-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[ Policies and Regulations of Chemical Machinery Equipment Network ] In accordance with the "Local Standards Management Measures" (Order No.
26 of the General Administration of Market Supervision) and the relevant regulations on the integration of Yangtze River Delta standards, Zhejiang Province* issued the "Yangtze River Delta Pharmaceutical Industry Air Pollutant Emission Standard" for comments The draft is now open for comments, and the deadline is September 7 to October 8, 2020.
If relevant units and individuals have opinions and suggestions, they can report to the Standardization Division of Zhejiang Provincial Market Supervision Bureau through letters, calls, visits, etc.
Chemical Machinery and Equipment Network Policies and Regulations Chemical Machinery and Equipment26 of the General Administration of Market Supervision) and the relevant regulations on the integration of Yangtze River Delta standards, Zhejiang Province* issued the "Yangtze River Delta Pharmaceutical Industry Air Pollutant Emission Standard" for comments The draft is now open for comments, and the deadline is September 7 to October 8, 2020.
If relevant units and individuals have opinions and suggestions, they can report to the Standardization Division of Zhejiang Provincial Market Supervision Bureau through letters, calls, visits, etc.
The pharmaceutical industry is an industry involving the national economy and the people's livelihood, and it also belongs to the fine chemical industry.
It has always been a key industry for environmental pollution control.
The pharmaceutical industry is characterized by a wide variety of production varieties, intermittent operations, long production processes, a large variety of raw materials used, large quantities, and low raw material utilization.
Therefore, the amount of "three wastes" is large, the waste components are complex, and pollution is serious.
The pharmaceutical industry is also one of the important sources of volatile organic compounds, and has always been a key industry for VOCs governance.
It has always been a key industry for environmental pollution control.
The pharmaceutical industry is characterized by a wide variety of production varieties, intermittent operations, long production processes, a large variety of raw materials used, large quantities, and low raw material utilization.
Therefore, the amount of "three wastes" is large, the waste components are complex, and pollution is serious.
The pharmaceutical industry is also one of the important sources of volatile organic compounds, and has always been a key industry for VOCs governance.
The Yangtze River Delta region has always attached great importance to the control of VOCs in the pharmaceutical industry.
According to the VOCs emission inventory of three provinces and one city, Shanghai contributed 0.
38%, Jiangsu Province contributed 2.
2%, Zhejiang Province contributed 10%, and Anhui Province contributed 0.
5%.
Shanghai has issued DB31/373-2010 "Emission Standards for Pollutants for the Biopharmaceutical Industry" since 2006 and revised in 2010; Zhejiang Province issued DB33/923-2014 "Emission Standards for Pollutants for the Biopharmaceutical Industry" in 2014 , Released DB33/2015-2016 "Chemical Synthesis Pharmaceutical Industry Air Pollutant Emission Standards" in 2016; Jiangsu Province issued DB33/2015-2016 "Biopharmaceutical Industry Water and Air Pollutant Emission Limits" in 2016.
As the national industry emission standard GB37823-2019 "Pharmaceutical Industry Air Pollutant Emission Standard" stipulates the standard application scope, standard index system, control index limit and unorganized emission control are very different from local standards, so local standards are Facing revision.
According to the VOCs emission inventory of three provinces and one city, Shanghai contributed 0.
38%, Jiangsu Province contributed 2.
2%, Zhejiang Province contributed 10%, and Anhui Province contributed 0.
5%.
Shanghai has issued DB31/373-2010 "Emission Standards for Pollutants for the Biopharmaceutical Industry" since 2006 and revised in 2010; Zhejiang Province issued DB33/923-2014 "Emission Standards for Pollutants for the Biopharmaceutical Industry" in 2014 , Released DB33/2015-2016 "Chemical Synthesis Pharmaceutical Industry Air Pollutant Emission Standards" in 2016; Jiangsu Province issued DB33/2015-2016 "Biopharmaceutical Industry Water and Air Pollutant Emission Limits" in 2016.
As the national industry emission standard GB37823-2019 "Pharmaceutical Industry Air Pollutant Emission Standard" stipulates the standard application scope, standard index system, control index limit and unorganized emission control are very different from local standards, so local standards are Facing revision.
This standard specifies the requirements for the control, monitoring and supervision of the emission of air pollutants in the pharmaceutical industry.
The discharge of water pollutants, environmental noise, nuclear and radiation from pharmaceutical industrial enterprises or production facilities shall be subject to the corresponding national or local pollutant discharge standards, and the identification, treatment and disposal of solid waste generated shall be subject to the corresponding national solid waste pollution control standards.
This standard is an integrated environmental protection standard for the Yangtze River Delta.
Since the date of implementation of the standard, the air pollutant emissions of pharmaceutical industry enterprises in Shanghai, Jiangsu, Zhejiang and Anhui Provinces shall be implemented in accordance with the provisions of this standard, and for indicators not covered by this standard The project is implemented in accordance with the national or local comprehensive emission standards for air pollutants.
Since the date of implementation of the standard, the air pollutant emissions of pharmaceutical industry enterprises in Shanghai, Jiangsu, Zhejiang and Anhui Provinces shall be implemented in accordance with the provisions of this standard, and for indicators not covered by this standard The project is implemented in accordance with the national or local comprehensive emission standards for air pollutants.
This standard is the basic requirement for the control of air pollutant emissions in the pharmaceutical industry.
After the promulgation and implementation of this standard, the state will promulgate corresponding industry pollutant emission standards that involve pollutant items that are not specified in this standard or the emission limit is stricter than this standard, the requirements of the national applicable standard will be implemented.
After the promulgation and implementation of this standard, the state will promulgate corresponding industry pollutant emission standards that involve pollutant items that are not specified in this standard or the emission limit is stricter than this standard, the requirements of the national applicable standard will be implemented.
The documents or clauses cited in this standard are: GB/T 4754-2017 Classification of National Economic Industries; GB/T 13554 High Efficiency Air Filter , GB 14554 Odor Pollutant Emission Standard; GB/T 14669 Air Quality Determination of Ammonia by Ion Selective Electrode Method ; GB/T 14675 Air quality determination of malodorous three-point comparative odor bag method; GB/T 14678 Air quality determination of hydrogen sulfide, methyl mercaptan, methyl sulfide and dimethyl disulfide gas chromatography; GB/T 15516 air Determination of quality formaldehyde; Acetylacetone spectrophotometry; GB/T 16157 Determination of particulate matter in exhaust from stationary sources and sampling methods for gaseous pollutants; GB 37823 Emission standard for air pollutants in the pharmaceutical industry; HJ/T 27 Determination of hydrogen chloride in exhaust from stationary sources Mercury thiocyanate spectrophotometric method; HJ/T 28 Determination of hydrogen cyanide in stationary source exhaust isonicotinic acid-pyrazolone spectrophotometry; HJ/T 30 Determination of chlorine in stationary source exhaust Methyl orange spectroscopy Photometric method; HJ/T 31 Determination of phosgene in stationary source exhaust aniline UV spectrophotometry; HJ/T 33 Determination of methanol in stationary source exhaust gas chromatography; HJ/T 34 Determination of vinyl chloride in stationary source exhaust Determination of gas chromatography; HJ/T 35 gas chromatography for the determination of acetaldehyde in exhaust gas from stationary sources; HJ/T 36 gas chromatography for the determination of acrolein in exhaust gas from stationary sources.
filter This standard specifies the requirements for the control, monitoring and supervision of the emission of air pollutants in the pharmaceutical industry.
This standard applies to the management of air pollutant emissions from existing pharmaceutical industrial enterprises or production facilities, as well as the environmental impact assessment of pharmaceutical industry construction projects, environmental protection facility design, environmental protection acceptance after completion, and the issuance of pollution discharge permits and air pollution after they are put into production.
Emissions management.
Emissions management.
This standard is also applicable to the management of air pollutant emissions from pharmaceutical intermediate companies and their production facilities, drug research and development institutions and their experimental facilities for pharmaceutical production.
The pharmaceutical industry to which this standard applies refers to the pharmaceutical manufacturing industry (C27) specified in GB/T 4754-2017, including the manufacturing of chemical raw materials (C271), the manufacturing of chemical preparations (C272), the processing of Chinese herbal medicines (C273), and proprietary Chinese medicines.
Production (C274), veterinary medicine manufacturing (C275), and biopharmaceutical products manufacturing (C276).
The manufacturing of sanitary materials and medical supplies (C277) and pharmaceutical excipients and packaging materials (C278) still comply with the requirements of GB37823 and are not applicable to this standard.
(See the attachment for more details)
Production (C274), veterinary medicine manufacturing (C275), and biopharmaceutical products manufacturing (C276).
The manufacturing of sanitary materials and medical supplies (C277) and pharmaceutical excipients and packaging materials (C278) still comply with the requirements of GB37823 and are not applicable to this standard.
(See the attachment for more details)
Original title: "Yangtze River Delta Pharmaceutical Industry Air Pollutant Emission Standards" Soliciting Comments